ABPI CEO Stephen Whitehead comments on the All-Party Pharmacy Group (APPG) inquiry into the issue of shortages in NHS prescription medicines, published on Tuesday 15 May.
Yesterday, the Home Office announced the UK animal research statistics for 2011. Most of the media reporting has been balanced, but there has been some disappointing coverage so it is worth investigating the Home Office figures in a little detail.
The pharmaceutical industry has a story to tell. But it’s not always a story that’s easy to understand or straightforward. The question is, how do we best tell our story and make sure our patients and stakeholders get to see real pharma?
Public Health England’s National Cancer Intelligence Network (NCIN) recently published their ‘Kidney Cancer Survival Report’, which shows that kidney cancer survival has improved in the last 20 years (1).
Today we have published a write-up of an event we held in late April on ‘Understanding the Early Access to Medicines Scheme’ (EAMS).
The concept of maintaining a “stiff upper lip”—not showing any emotion—is something that many people think characterises the British. It is an antiquated stereotype that has left us with a reputation for being reserved and reluctant to express our feelings.
As the ABPI launches its latest research showing significant barriers to the NHS accessing life-saving and life-enhancing stratified medicines, ABPI Chief Executive Stephen Whitehead considers why the Government’s new Innovative Medicines and MedTech Review into the pathway for development,...
The ABPI and the National Institute for Health Research (NIHR) are holding a national conference about the UK’s evolving data boom and its potential for the biopharmaceutical industry and the NHS.
Antibiotics have without doubt, revolutionised modern medicine. Since the time of their discovery they have saved millions of lives, and improved the quality of countless others not just in treating infections but also in less commonly known areas such as prophylaxis.
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has announced today the Innovative Medicines Initiative 2 (IMI2). This is a 10-year public-private collaboration which aims to speed-up medical breakthroughs urgently needed to tackle the growing healthcare challenges...
The joint report by the NHS Confederation, National Voices and the Academy of Medical Royal Colleges highlights once again the scale of the long-term funding challenges facing the NHS. The report also demonstrates starkly the need for radical thinking about how these financial challenges can be...